Bioisosteric Replacement and Scaffold Hopping in Lead Generation and Optimization

Bioisosteric replacement and scaffold hopping are twin methods used in drug design to improve the synthetic accessibility, potency and drug like properties of a compound and to move into novel chemical space. Bioisosteric replacement involves swapping functional groups of a molecule with other functional groups that have similar biological properties. Scaffold hopping is the replacement of the core framework of a molecule with another scaffold that will improve the properties of the molecule or to find similar potent compounds that exist in novel chemical space. This review outlines the key concepts, importance and challenges of both methods using examples and comparisons of techniques available for finding bioisosteric replacements and scaffold hops. There are many methods available for bioisosteric replacement and scaffold hopping, all with their own advantages and disadvantages. Drug design projects would benefit from a combination of these methods to retrieve diverse and complimentary results. Continuing progress in these fields will allow further validation of both methods as well as the accumulation of knowledge on bioisosteres and possible scaffold replacements.

[1]  R. Todeschini,et al.  Molecular Descriptors for Chemoinformatics: Volume I: Alphabetical Listing / Volume II: Appendices, References , 2009 .

[2]  A. I. Glushkov,et al.  Orally bioavailable, liver-selective stearoyl-CoA desaturase (SCD) inhibitors. , 2009, Bioorganic & medicinal chemistry letters.

[3]  P. Willett,et al.  Use of Reduced Graphs To Encode Bioisosterism for Similarity-Based Virtual Screening , 2009, J. Chem. Inf. Model..

[4]  Michael Devereux,et al.  Quantum Isostere Database: A Web-Based Tool Using Quantum Chemical Topology To Predict Bioisosteric Replacements for Drug Design , 2009, J. Chem. Inf. Model..

[5]  Gisbert Schneider,et al.  Scaffold-hopping potential of fragment-based de novo design: the chances and limits of variation. , 2009, Combinatorial chemistry & high throughput screening.

[6]  M. Lehr,et al.  1-(5-Carboxyindol-1-yl)propan-2-ones as inhibitors of human cytosolic phospholipase A2alpha: synthesis and properties of bioisosteric benzimidazole, benzotriazole and indazole analogues. , 2009, Bioorganic & medicinal chemistry letters.

[7]  W. Pitt,et al.  Heteroaromatic rings of the future. , 2009, Journal of medicinal chemistry.

[8]  Mark S. Johnson,et al.  ShaEP: Molecular Overlay Based on Shape and Electrostatic Potential , 2009, J. Chem. Inf. Model..

[9]  Gisbert Schneider,et al.  Scaffold diversity of natural products: inspiration for combinatorial library design. , 2008, Natural product reports.

[10]  Wolfgang Guba,et al.  Recent developments in de novo design and scaffold hopping. , 2008, Current opinion in drug discovery & development.

[11]  Gisbert Schneider,et al.  Shapelets: Possibilities and limitations of shape‐based virtual screening , 2008, J. Comput. Chem..

[12]  W. Graham Richards,et al.  Ultrafast shape recognition to search compound databases for similar molecular shapes , 2007, J. Comput. Chem..

[13]  Pierre Bruneau,et al.  A Database of Historically-Observed Chemical Replacements , 2007, J. Chem. Inf. Model..

[14]  Nathan Brown,et al.  Molecular optimization using computational multi-objective methods. , 2007, Current opinion in drug discovery & development.

[15]  Peter Ertl,et al.  In silico identification of bioisosteric functional groups. , 2007, Current opinion in drug discovery & development.

[16]  Christopher I. Bayly,et al.  Evaluating Virtual Screening Methods: Good and Bad Metrics for the "Early Recognition" Problem , 2007, J. Chem. Inf. Model..

[17]  Jeremy L. Jenkins,et al.  Clustering and Rule-Based Classifications of Chemical Structures Evaluated in the Biological Activity Space , 2007, J. Chem. Inf. Model..

[18]  Hongyu Zhao,et al.  Scaffold selection and scaffold hopping in lead generation: a medicinal chemistry perspective. , 2007, Drug discovery today.

[19]  Gisbert Schneider,et al.  Scaffold‐Hopping: How Far Can You Jump? , 2006 .

[20]  Nathan Brown,et al.  On scaffolds and hopping in medicinal chemistry. , 2006, Mini reviews in medicinal chemistry.

[21]  Andrew G. Leach,et al.  Matched molecular pairs as a guide in the optimization of pharmaceutical properties; a study of aqueous solubility, plasma protein binding and oral exposure. , 2006, Journal of medicinal chemistry.

[22]  Peter Willett,et al.  Identification of target-specific bioisosteric fragments from ligand–protein crystallographic data , 2006, J. Comput. Aided Mol. Des..

[23]  C. Brochu,et al.  Improved replicon cellular activity of non-nucleoside allosteric inhibitors of HCV NS5B polymerase: from benzimidazole to indole scaffolds. , 2006, Bioorganic & medicinal chemistry letters.

[24]  David Rogers,et al.  Cheminformatics analysis and learning in a data pipelining environment , 2006, Molecular Diversity.

[25]  R. Cramer,et al.  Leadhopping – and beyond , 2006, Expert opinion on drug discovery.

[26]  Peter Gedeck,et al.  QSAR - How Good Is It in Practice? Comparison of Descriptor Sets on an Unbiased Cross Section of Corporate Data Sets , 2006, J. Chem. Inf. Model..

[27]  Peter Willett,et al.  Unsupervised 3D Ring Template Searching as an Ideas Generator for Scaffold Hopping: Use of the LAMDA, RigFit, and Field-Based Similarity Search (FBSS) Methods , 2006, J. Chem. Inf. Model..

[28]  Peter Ertl,et al.  Quest for the rings. In silico exploration of ring universe to identify novel bioactive heteroaromatic scaffolds. , 2006, Journal of medicinal chemistry.

[29]  Ajay,et al.  Kinase patent space visualization using chemical replacements. , 2006, Journal of medicinal chemistry.

[30]  G. Schneider,et al.  Scaffold‐Hopping Potential of Ligand‐Based Similarity Concepts , 2006, ChemMedChem.

[31]  Andrea Zaliani,et al.  A Knowledge-Based Weighting Approach to Ligand-Based Virtual Screening , 2006, J. Chem. Inf. Model..

[32]  Markus Wagener,et al.  The Quest for Bioisosteric Replacements , 2006, J. Chem. Inf. Model..

[33]  Didier Rognan,et al.  Assessing the Scaffold Diversity of Screening Libraries , 2006, J. Chem. Inf. Model..

[34]  Andy Vinter,et al.  Molecular Field Extrema as Descriptors of Biological Activity: Definition and Validation , 2006, J. Chem. Inf. Model..

[35]  Peter Willett,et al.  Scaffold Hopping Using Clique Detection Applied to Reduced Graphs , 2006, J. Chem. Inf. Model..

[36]  Jérôme Hert,et al.  New Methods for Ligand-Based Virtual Screening: Use of Data Fusion and Machine Learning to Enhance the Effectiveness of Similarity Searching , 2006, J. Chem. Inf. Model..

[37]  J. G. Vinter,et al.  Scaffold hopping with molecular field points: identification of a cholecystokinin-2 (CCK2) receptor pharmacophore and its use in the design of a prototypical series of pyrrole- and imidazole-based CCK2 antagonists. , 2005, Journal of medicinal chemistry.

[38]  G. Schneider,et al.  New Allosteric Modulators of Metabotropic Glutamate Receptor 5 (mGluR5) Found by Ligand‐Based Virtual Screening , 2005, Chembiochem : a European journal of chemical biology.

[39]  Andrew I Su,et al.  HierS: hierarchical scaffold clustering using topological chemical graphs. , 2005, Journal of medicinal chemistry.

[40]  J. A. Grant,et al.  A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction. , 2005, Journal of medicinal chemistry.

[41]  Robert J. Jilek,et al.  "Lead hopping". Validation of topomer similarity as a superior predictor of similar biological activities. , 2004, Journal of medicinal chemistry.

[42]  J. Jenkins,et al.  A 3D similarity method for scaffold hopping from known drugs or natural ligands to new chemotypes. , 2004, Journal of medicinal chemistry.

[43]  G. S. Gill,et al.  Molecular surface point environments for virtual screening and the elucidation of binding patterns (MOLPRINT) , 2004, 2004 IEEE International Conference on Systems, Man and Cybernetics (IEEE Cat. No.04CH37583).

[44]  G. Schneider,et al.  Fuzzy pharmacophore models from molecular alignments for correlation-vector-based virtual screening. , 2004, Journal of medicinal chemistry.

[45]  G. Harper,et al.  The reduced graph descriptor in virtual screening and data-driven clustering of high-throughput screening data. , 2004, Journal of chemical information and computer sciences.

[46]  Ian A. Watson,et al.  Selection of heterocycles for drug design. , 2004, Journal of molecular graphics & modelling.

[47]  Anthony Nicholls,et al.  Variable selection and model validation of 2D and 3D molecular descriptors> , 2004, J. Comput. Aided Mol. Des..

[48]  Yi Li,et al.  Analysis and optimization of structure-based virtual screening protocols. 2. Examination of docked ligand orientation sampling methodology: mapping a pharmacophore for success. , 2003, Journal of molecular graphics & modelling.

[49]  Gavin Harper,et al.  Drug rings database with web interface. A tool for identifying alternative chemical rings in lead discovery programs. , 2003, Journal of medicinal chemistry.

[50]  Pierre Acklin,et al.  Similarity Metrics for Ligands Reflecting the Similarity of the Target Proteins , 2003, J. Chem. Inf. Comput. Sci..

[51]  Peter Ertl,et al.  Cheminformatics Analysis of Organic Substituents: Identification of the Most Common Substituents, Calculation of Substituent Properties, and Automatic Identification of Drug-like Bioisosteric Groups , 2003, J. Chem. Inf. Comput. Sci..

[52]  John Bradshaw,et al.  Similarity Searching Using Reduced Graphs , 2003, J. Chem. Inf. Comput. Sci..

[53]  Peter Gedeck,et al.  Calculation of Intersubstituent Similarity Using R-Group Descriptors , 2003, J. Chem. Inf. Comput. Sci..

[54]  Peter Willett,et al.  Scaffold Searching: Automated Identification of Similar Ring Systems for the Design of Combinatorial Libraries , 2002 .

[55]  James G. Nourse,et al.  Reoptimization of MDL Keys for Use in Drug Discovery , 2002, J. Chem. Inf. Comput. Sci..

[56]  Christos A. Nicolaou,et al.  Analysis of Large Screening Data Sets via Adaptively Grown Phylogenetic-Like Trees , 2002, J. Chem. Inf. Comput. Sci..

[57]  Mark Johnson,et al.  Using Molecular Equivalence Numbers To Visually Explore Structural Features that Distinguish Chemical Libraries , 2002, J. Chem. Inf. Comput. Sci..

[58]  Peter J. Fleming,et al.  Combinatorial Library Design Using a Multiobjective Genetic Algorithm , 2002, J. Chem. Inf. Comput. Sci..

[59]  Robert P. Sheridan,et al.  The Most Common Chemical Replacements in Drug-Like Compounds , 2002, J. Chem. Inf. Comput. Sci..

[60]  Paul Watson,et al.  Calculating the knowledge-based similarity of functional groups using crystallographic data , 2001, J. Comput. Aided Mol. Des..

[61]  D. Manallack,et al.  Theoretical hydrogen bonding parameters for drug design. , 2001, Journal of molecular graphics & modelling.

[62]  Matthias Rarey,et al.  Similarity searching in large combinatorial chemistry spaces , 2001, J. Comput. Aided Mol. Des..

[63]  Michael H. Abraham,et al.  Hydrogen bond structural group constants. , 2001, The Journal of organic chemistry.

[64]  Darren V. S. Green,et al.  Where Are the GaPs? A Rational Approach to Monomer Acquisition and Selection , 2000, J. Chem. Inf. Comput. Sci..

[65]  Schmid,et al.  "Scaffold-Hopping" by Topological Pharmacophore Search: A Contribution to Virtual Screening. , 1999, Angewandte Chemie.

[66]  Matthias Rarey,et al.  Feature trees: A new molecular similarity measure based on tree matching , 1998, J. Comput. Aided Mol. Des..

[67]  Michael M. Hann,et al.  RECAP-Retrosynthetic Combinatorial Analysis Procedure: A Powerful New Technique for Identifying Privileged Molecular Fragments with Useful Applications in Combinatorial Chemistry , 1998, J. Chem. Inf. Comput. Sci..

[68]  Johann Gasteiger,et al.  Superposition of Three-Dimensional Chemical Structures Allowing for Conformational Flexibility by a Hybrid Method , 1998, J. Chem. Inf. Comput. Sci..

[69]  P Ertl,et al.  World Wide Web-based system for the calculation of substituent parameters and substituent similarity searches. , 1998, Journal of molecular graphics & modelling.

[70]  J. Yergey,et al.  Characterization of the in vitro oxidative metabolites of the COX-2 selective inhibitor L-766,112 , 1997 .

[71]  P. Prasit,et al.  A new series of selective COX-2 inhibitors : 5,6-diarylthiazolo[3,2-b][1,2,4]triazoles , 1997 .

[72]  Johann Gasteiger,et al.  The comparison of geometric and electronic properties of molecular surfaces by neural networks: Application to the analysis of corticosteroid-binding globulin activity of steroids , 1996, J. Comput. Aided Mol. Des..

[73]  J. Gasteiger,et al.  Comparison of structurally different allosteric modulators of muscarinic receptors by self-organizing neural networks. , 1996, Journal of molecular graphics.

[74]  Peter Willett,et al.  Similarity Searching in Files of Three-Dimensional Chemical Structures: Flexible Field-Based Searching of Molecular Electrostatic Potentials , 1996, J. Chem. Inf. Comput. Sci..

[75]  G. Bemis,et al.  The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.

[76]  Andrew W. Lloyd,et al.  Selective estrogen receptor modulators , 1996 .

[77]  Peter Willett,et al.  Similarity Searching in Files of Three-Dimensional Chemical Structures. Alignment of Molecular Electrostatic Potential Fields with a Genetic Algorithm , 1996, J. Chem. Inf. Comput. Sci..

[78]  Robert P. Sheridan,et al.  Chemical Similarity Using Physiochemical Property Descriptors , 1996, J. Chem. Inf. Comput. Sci..

[79]  Toshio Fujita,et al.  Classical and Three-Dimensional QSAR in Agrochemistry , 1995 .

[80]  H. Kubinyi QSAR: Hansch Analysis and Related Approaches: Kubinyi/QSAR , 1993 .

[81]  Peter J. Rousseeuw,et al.  Finding Groups in Data: An Introduction to Cluster Analysis , 1990 .

[82]  Michael F. Lynch,et al.  Computer storage and retrieval of generic chemical structures in patents. 13. Reduced graph generation , 1991, J. Chem. Inf. Comput. Sci..

[83]  Corwin Hansch,et al.  A survey of Hammett substituent constants and resonance and field parameters , 1991 .

[84]  J. Barnard A comparison of different approaches to Markush structure handling , 1991, J. Chem. Inf. Comput. Sci..

[85]  Valerie J. Gillet,et al.  Computer storage and retrieval of generic chemical structures in patents. 8. Reduced chemical graphs and their applications in generic chemical structure retrieval , 1987, J. Chem. Inf. Comput. Sci..

[86]  Gordon M. Crippen,et al.  Atomic physicochemical parameters for three-dimensional-structure-directed quantitative structure-activity relationships. 2. Modeling dispersive and hydrophobic interactions , 1987, J. Chem. Inf. Comput. Sci..

[87]  C. Bron,et al.  Algorithm 457: finding all cliques of an undirected graph , 1973 .

[88]  P. N. Craig,et al.  Interdependence between physical parameters and selection of substituent groups for correlation studies. , 1971, Journal of medicinal chemistry.

[89]  B. R. Baker,et al.  Irreversible enzyme inhibitors. 158. Effect of bridge modification on the selective irreversible inhibition of dihydrofolic reductase from L1210 mouse leukemia and liver by 2,4-diamino-5-(3,4-dichlorophenyl)-6-[p-(m-fluorosulfonylbenzamidomethyl)phenoxymethyl]pyrimidine. II. , 1969, Journal of medicinal chemistry.

[90]  Donald J. Cram,et al.  Macro rings. XXXVII. Multiple electrophilic substitution reactions of [2.2]paracyclophanes and interconversions of polysubstituted derivatives , 1969 .

[91]  I. Langmuir ISOMORPHISM, ISOSTERISM AND COVALENCE. , 1919 .

[92]  Roberto Todeschini,et al.  Molecular descriptors for chemoinformatics , 2009 .

[93]  Bruno Giethlen,et al.  Molecular Variations Based on Isosteric Replacements , 2008 .

[94]  Stefan Wetzel,et al.  The Scaffold Tree - Visualization of the Scaffold Universe by Hierarchical Scaffold Classification , 2007, J. Chem. Inf. Model..

[95]  Ian A. Watson,et al.  ErG: 2D Pharmacophore Descriptions for Scaffold Hopping , 2006, J. Chem. Inf. Model..

[96]  Thomas Lengauer,et al.  Novel technologies for virtual screening. , 2004, Drug discovery today.

[97]  Teuvo Kohonen,et al.  Self-organized formation of topologically correct feature maps , 2004, Biological Cybernetics.

[98]  C. Wermuth,et al.  13 – MOLECULAR VARIATIONS BASED ON ISOSTERIC REPLACEMENTS , 2003 .

[99]  Peter Willett,et al.  RASCAL: Calculation of Graph Similarity using Maximum Common Edge Subgraphs , 2002, Comput. J..

[100]  Peter Ertl,et al.  Simple Quantum Chemical Parameters as an Alternative to the Hammett Sigma Constants in QSAR Studies , 1997 .

[101]  H. Kubinyi QSAR : Hansch analysis and related approaches , 1993 .

[102]  W. G. Richards,et al.  Rapid evaluation of shape similarity using Gaussian functions , 1993, J. Chem. Inf. Comput. Sci..

[103]  P. Broto,et al.  Molecular structures: perception, autocorrelation descriptor and sar studies. Autocorrelation descriptor , 1984 .

[104]  T. Kohonen Self-organized formation of topographically correct feature maps , 1982 .

[105]  A. H. Lipkus,et al.  Structural Diversity of Organic Chemistry. a Scaffold Analysis of the Cas Registry , 2022 .